Photo of Lee A. A. Baumgardner

On June 15, the Eastern District of California, Judge Morrison J. England, granted CBD retailer Global Widget, LLC’s (“Global Widget”) request to stay the case of Glass v. Global Widget LLC, Case No. 2:19-cv-01906 (E.D. Cal.) until the U.S. Food and Drug Administration (“FDA”) completes its rulemaking regarding the marketing and labelling of CBD

Green Marketing PodcastAs we have written about extensively on this blog, consumers continue to grow more environmentally conscious and demand products that reflect this concern. To meet consumer demands and as part of social responsibility initiatives, companies are increasing their “sustainable” practices, recycling materials, upcycling other products, and working to reduce waste and environmental harms.  As

Fashion Brands Continue Focus on Green MarketingTo celebrate the 50th Anniversary of Earth Day this week, we look at the increasingly pressing topic of green marketing in the fashion industry.  Recent studies have shown that environmentally conscious consumers continue to grow in number and demand products that have a reduced effect on the environment.  To meet this demand and as

On April 23, the California Assembly’s Committee on Privacy and Consumer Protection held a hearing to discuss a number of proposed amendments to the California Consumer Privacy Act (CCPA).  Here are some of the key bills the Committee voted to move forward:

On Tuesday, the California Senate Judiciary Committee will hold a hearing to discuss SB-753, which, if adopted, would carve out from the California Consumer Privacy Act (CCPA)’s definition of “sale” certain data sharing for purposes of delivering advertising. As we’ve previously noted, the CCPA is intended to afford consumers the right to know

The FDA and FTC jointly issued warning letters to three companies selling CBD products online.  The letters allege violations of the Federal Food, Drug, and Cosmetic Act (“FDCA”) and the Federal Trade Commission Act (“FTCA”).  Although this is the first time the FDA and FTC have issued joint warning letters relating to CBD, the FDA